Brief: Galmed Pharmaceuticals Reports Q2 Loss Per Share Of $0.15

Eocene

04/08/2022 14:04

Aug 4 (Reuters) - Galmed Pharmaceuticals Ltd  GLMD.O :
    * GALMED PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND
REPORTS
SECOND QUARTER 2022 FINANCIAL RESULTS
    * Q2 LOSS PER SHARE $0.15
    * Q2 EARNINGS PER SHARE VIEW $-0.24 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn8pxxcya 
Further company coverage:  GLMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))